for its repurposing as a therapeutic agent for the treatment of severe Covid-19.

2. Results and Discussion
In order to have a preliminary insight into the affinity of ralixofene towards the bradykinin receptors, the compound was first tested at 20 µM for its capacity to displace a reference ligand from B1 and B2, respectively. Specifically, desArg10-kal